Hass하스
450330 · KOSDAQ · ₩450330 · 하스
- Market cap
- ₩34B
- Enterprise value
- ₩26B
- P/E
- —
- P/B
- 0.8×
- Dividend yield
- 1.5%
- ROE
- −0.4%
- Net margin
- −1.0%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−52.6% from the high
₩3,650Today: ₩4,040 – ₩4,155₩8,700
Returns
- 1W−10.1%
- 1M−14.5%
- 3M+7.4%
- 6M−43.1%
- YTD−34.2%
- 1Y−40.0%
- Volume today
- 1,701
- 0.2× the 20-day average
- Traded today
- ₩6.9M
- Listed shares
- 8,186,843
- EPS (12 months)
- −₩19
- Earnings yield −0.5%
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 28 of 100 (50 is a normal day for this stock).
- MomentumWeak-15.8% over the last month; the price is below its 20-day average.
Signals describe activity, not recommendations. Not financial advice.
Hass stock overview
Hass (하스, KRX: 450330) is listed on KOSDAQ, in the Biotech & Pharma sector. The company, founded in 2008, manufactures dental restorative materials, mainly lithium disilicate glass-ceramics and zirconia, for dental prosthetic restorations. Its shares closed at ₩4,125 on Oct 28, 2026, up 0.73% on the day, giving it a market value of ₩34B.
Key facts
- Market cap
- ₩34B
- Sector
- Biotech & Pharma
- Latest price change
- +0.73%
- As of
- Oct 28, 2026
- Main business
- The company, founded in 2008, manufactures dental restorative materials, mainly lithium disilicate glass-ceramics and zirconia, for dental prosthetic restorations.
Quick answers about Hass
- What does Hass do?
- The company, founded in 2008, manufactures dental restorative materials, mainly lithium disilicate glass-ceramics and zirconia, for dental prosthetic restorations. Its product lines include Amber and Rosetta blocks and ingots, NuSmile ZR, and Zirtooth, which it sells to dental laboratories and dental clinics, with major customers including dental distributors and manufacturers. It sells in Korea and overseas through its sales organization, including subsidiaries in the United States and China and a branch in Europe.
- What is the market cap of Hass?
- The market capitalisation of Hass was ₩34B at the close on Oct 28, 2026.
- Who are the largest shareholders of Hass?
- According to the latest official filings, the largest reported holders are Kim Yong-su (60.72%, as of Sep 1, 2025); Im Hyeong-bong (1.96%, as of Aug 6, 2025); Hong Yeong-pyo (0.47%, as of Aug 7, 2025).
- When is the next earnings report from Hass?
- Korean companies rarely announce results dates in advance. Based on when Hass filed the same report in past years, its next 3q results is expected between Nov 14, 2026 and Nov 28, 2026.
Company profile
The company, founded in 2008, manufactures dental restorative materials, mainly lithium disilicate glass-ceramics and zirconia, for dental prosthetic restorations. Its product lines include Amber and Rosetta blocks and ingots, NuSmile ZR, and Zirtooth, which it sells to dental laboratories and dental clinics, with major customers including dental distributors and manufacturers. It sells in Korea and overseas through its sales organization, including subsidiaries in the United States and China and a branch in Europe.
Written by AI from the company's latest annual report.
- Korean name
- 하스
- Sector
- Biotech & Pharma
- Themes
- Biotech (new drugs)
- CEO
- 김용수
- Founded
- Jan 2008
- Listed
- Jul 2024
- Listed shares
- 8,186,843
- Fiscal year ends
- Month 12
- Website
- www.hassbio.com
Similar companies
- Samsung Biologics207940 · ₩64T₩1,372,000−0.15%
- Celltrion068270 · ₩44T₩189,800+0.64%
- Alteogen196170 · ₩16T₩223,000+2.06%
- SK biopharmaceuticals326030 · ₩5.9T₩75,200+0.40%
- Yuhan000100 · ₩5.7T₩77,300−3.38%
- HLB028300 · ₩5.4T₩40,650+1.88%
- Hanmi Pharm128940 · ₩4.7T₩369,500+5.42%
- SAM Chun Dang Pharm000250 · ₩4.5T₩190,000+1.28%
Recent filings
See all- Half-year report (Jun 2026)Aug 13, 2026
- Buyback trust contract signedAug 11, 2026
- Quarterly report (Mar 2026)May 14, 2026
- Trust Contract Termination Result ReportMay 4, 2026
- Material Matters Report (Decision on Termination of Trust Agreement for Own Share Acquisition)Apr 30, 2026
Titles in Korean until English translations are added.
Also known as: Hass / 하스 / 450330 / KRX:450330
Source: KRX statistical information